Relationship between metastasis of canine malignant melanoma and membrane glycoprotein AD-1 (CD 63)

犬恶性黑色素瘤转移与膜糖蛋白AD-1(CD 63)的关系

基本信息

  • 批准号:
    10839004
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Canine malignant melanoma has been known to be quite malignant with rapid growth, wide local invasion, early metastasis, resistant to chemotherapy and radiotherapy and quite early metastasis. In mice, membrane glycoprotein, AD-1 or CD 63, has been known that it appears in the primary lesion but disappears in the metastatic lesion, therefore may play a role in the mechanism of the tumor metastasis. The purpose of this study is to clarify the role of AD-1 in the metastasis of canine malignant melanoma.In the first experiment, establishment of melanoma cell lines from the canine patients were conducted. Four cell lines originated from the oral membrane and skin with different proliferation manner and transplantability to nude mice were established.Using one of these cells, production of the monoclonal antibody to AD-1 was conducted. As a result, two antibodies were obrtained. One reacted only to melanoma cells and the other reacted to both melanoma and mastocytoma cells, which are known to have AD-1. Unfortunately it is still not demonstrated whether these antibodies are specific to AD-1.These two antibodies were used for the histochemistry of spontaneous canine melanoma tissues obtained at surgery. As a result, the former antibody reacted to either primary or metastatic lesions ; in some specimens, positive in the primary tissues and negative in the metastatic tissues, whereas in other tissues, positive in the metastatic tissues and negative in the primary tissues. This may suggest this antigody recognizes some of the substance which may relate to metastasis, but perhaps not to AD-1 . Further study will be needed to clarify the substance recognized by these monoclonal antibodies and its role in the mechanism of metastasis in this tumor.
犬恶性黑色素瘤具有生长迅速、局部侵袭范围广、转移早、化疗和放疗耐药、转移早等特点。在小鼠中,已知膜糖蛋白AD-1或cd63在原发病变中出现,但在转移病变中消失,因此可能在肿瘤转移机制中发挥作用。本研究旨在阐明AD-1在犬恶性黑色素瘤转移中的作用。在第一个实验中,从犬患者身上建立黑色素瘤细胞系。分别从口腔粘膜和皮肤中培养了4株具有不同增殖方式和可移植性的细胞系。利用其中一个细胞,生产AD-1单克隆抗体。结果,获得了两种抗体。其中一种只对黑色素瘤细胞起反应,而另一种对黑色素瘤和肥大细胞瘤细胞都起反应,这两种细胞已知含有AD-1。不幸的是,目前还没有证明这些抗体是否对AD-1具有特异性。这两种抗体用于手术获得的自发性犬黑色素瘤组织的组织化学。结果,前一种抗体对原发性或转移性病变有反应;在一些标本中,原发组织呈阳性,转移组织呈阴性,而在其他组织中,转移组织呈阳性,原发组织呈阴性。这可能表明该抗体识别一些可能与转移有关的物质,但可能不识别AD-1。需要进一步研究这些单克隆抗体识别的物质及其在该肿瘤转移机制中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SASAKI Nobuo其他文献

Development of Less-Invasive Tracheal Tube Using Beagle Dogs
利用比格犬开发微创气管插管
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    FUJISAWA Ayano;SHIMOHATA Nobuyuki;ITOH Seiko;NAKAGAWA Takayuki;MOCHIZUKI Manabu;HAISHIMA Yuji;FUKUI Chie;KAWAKAMI Tsuyoshi;CHUNG Ung-il;SASAKI Nobuo
  • 通讯作者:
    SASAKI Nobuo

SASAKI Nobuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SASAKI Nobuo', 18)}}的其他基金

Developing a scalable-coculturing system for gut anaerobes and intestinal epithelium
开发肠道厌氧菌和肠上皮的可扩展共培养系统
  • 批准号:
    19K22544
  • 财政年份:
    2019
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Molecular and clinical analysis for metastasis and invasion of cancers in small animals
小动物癌症转移和侵袭的分子和临床分析
  • 批准号:
    15208030
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Basic amd clinical study on differentiation induction of solid tumors with frequent metastasis
多转移实体瘤分化诱导的基础与临床研究
  • 批准号:
    07456141
  • 财政年份:
    1995
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Chronic laminitis as the predisposing factor for other digital diseases in dairy cows
慢性蹄叶炎是奶牛其他指部疾病的诱发因素
  • 批准号:
    03454111
  • 财政年份:
    1991
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Estrogen and progesterone receptors in canine mammary tumors.
犬乳腺肿瘤中的雌激素和孕激素受体。
  • 批准号:
    60560330
  • 财政年份:
    1985
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development of a novel therapeutic drug targeting both MDM4 and PKC, critical points in uveal malignant melanoma
开发针对葡萄膜恶性黑色素瘤关键点 MDM4 和 PKC 的新型治疗药物
  • 批准号:
    23K09020
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel treatment targeting the immunosuppressive mechanism of MDSC for canine malignant melanoma
针对MDSC免疫抑制机制开发犬恶性黑色素瘤新疗法
  • 批准号:
    23K05561
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A new treatment for malignant melanoma based on the concept of compartmentalization of cAMP-PDE2 signal transduction
基于cAMP-PDE2信号转导区室化概念的恶性黑色素瘤新疗法
  • 批准号:
    22K10144
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of cancer progression induced by TGF-beta to develop novel therapies for canine malignant melanoma
阐明TGF-β诱导癌症进展的机制,开发犬恶性黑色素瘤的新疗法
  • 批准号:
    21K14973
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the effect of ALDH2 gene polymorphism on the onset and prognosis of malignant melanoma
阐明ALDH2基因多态性对恶性黑色素瘤发病及预后的影响
  • 批准号:
    21K16218
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
new therapeutic target molecules for malignant melanoma focusing on epigenomic information
关注表观基因组信息的恶性黑色素瘤新治疗靶分子
  • 批准号:
    21K16221
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Biomarkers for predicting response to immune checkpoint inhibitor therapy in malignant melanoma.
用于预测恶性黑色素瘤免疫检查点抑制剂治疗反应的生物标志物。
  • 批准号:
    20K07449
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
the role of HMGB1 in autophagy of malignant melanoma
HMGB1在恶性黑色素瘤自噬中的作用
  • 批准号:
    20K18438
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of cytoskeletal regulator Plectin in growth, invasion, and metastasis of malignant melanoma.
细胞骨架调节因子 Plectin 在恶性黑色素瘤生长、侵袭和转移中的作用。
  • 批准号:
    20K10185
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical role of EPCR expression in malignant melanoma
EPCR表达在恶性黑色素瘤中的临床作用
  • 批准号:
    20K17330
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了